Search Results

There are 43896 results for: content related to: Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I — A randomized study

  1. Monoclonal gammopathies of undetermined significance: a review

    Immunological Reviews

    Volume 194, Issue 1, August 2003, Pages: 112–139, Robert A. Kyle and S. Vincent Rajkumar

    Version of Record online : 7 JUL 2003, DOI: 10.1034/j.1600-065X.2003.00056.x

  2. You have free access to this content
    Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression

    British Journal of Haematology

    Volume 139, Issue 5, December 2007, Pages: 730–743, Robert A. Kyle and S. Vincent Rajkumar

    Version of Record online : 14 NOV 2007, DOI: 10.1111/j.1365-2141.2007.06873.x

  3. MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE

    Reviews in Clinical and Experimental Hematology

    Volume 6, Issue 3, September 2002, Pages: 225–252, Robert A. Kyle and S. Vincent Rajkumar

    Version of Record online : 1 NOV 2002, DOI: 10.1046/j.1468-0734.2002.00076.x

  4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

    European Journal of Haematology

    Volume 43, Issue S51, December 1989, Pages: 70–75, Robert A. Kyle

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1989.tb01496.x

  5. You have free access to this content
    Monoclonal gammopathy of undetermined significance

    British Journal of Haematology

    Volume 134, Issue 6, September 2006, Pages: 573–589, Robert A. Kyle and S. Vincent Rajkumar

    Version of Record online : 7 AUG 2006, DOI: 10.1111/j.1365-2141.2006.06235.x

  6. Prognostic value of serum M-protein doubling time at escape from plateau of multiple myeloma

    European Journal of Haematology

    Volume 57, Issue 3, September 1996, Pages: 247–253, Tiina M. Oivanen and Finnish Leukaemia Group

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1996.tb01371.x

  7. You have free access to this content
    Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone

    Cancer

    Volume 94, Issue 5, 1 March 2002, Pages: 1532–1537, Richard B. Wilder, Chul S. Ha, James D. Cox, Donna Weber, Kay Delasalle and Raymond Alexanian

    Version of Record online : 11 MAR 2002, DOI: 10.1002/cncr.10366

  8. You have free access to this content
    Smoldering multiple myeloma: natural history and recognition of an evolving type

    British Journal of Haematology

    Volume 123, Issue 4, November-II 2003, Pages: 631–636, L. Rosiñol, J. Bladé, J. Esteve, M. Aymerich, M. Rozman, S. Montoto, E. Giné, E. Nadal, X. Filella, R. Queralt, A. Carrió and E. Montserrat

    Version of Record online : 6 NOV 2003, DOI: 10.1046/j.1365-2141.2003.04654.x

  9. You have free access to this content
    UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

    British Journal of Haematology

    Volume 147, Issue 1, October 2009, Pages: 22–42, Jenny Bird, Judith Behrens, Jan Westin, Ingemar Turesson, Mark Drayson, Robert Beetham, Shirley D’Sa, Richard Soutar, Anders Waage, Nina Gulbrandsen, Henrik Gregersen, Eric Low and Writing group: On behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group

    Version of Record online : 10 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07807.x

    Corrected by:

    Corrigendum

    Vol. 148, Issue 3, 491, Version of Record online: 11 JAN 2010

  10. You have free access to this content
    Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil

    British Journal of Haematology

    Volume 108, Issue 4, March 2000, Pages: 737–742, Robert A. Kyle, Philip R. Greipp, Morie A. Gertz, Thomas E. Witzig, John A. Lust, Martha Q. Lacy and Terry M. Therneau

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2141.2000.01918.x

  11. Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis

    Journal of Clinical Laboratory Analysis

    Volume 14, Issue 2, 2000, Pages: 64–69, Yuriko Kurihara, Kiyoko Shiba, Yukihito Fukumura, Isao Kobayashi and Sachiko Kamei

    Version of Record online : 22 FEB 2000, DOI: 10.1002/(SICI)1098-2825(2000)14:2<64::AID-JCLA5>3.0.CO;2-O

  12. THE TREATMENT OF PLASMA CELL MYELOMA

    British Journal of Haematology

    Volume 33, Issue 4, August 1976, Pages: 443–449, Daniel E. Bergsagel

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1976.tb03562.x

  13. Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia

    International Journal of Laboratory Hematology

    Volume 35, Issue 4, August 2013, Pages: 421–427, S. Pandey, S. R. Post, D. V. Alapat, K. J. Smock and G. R. Post

    Version of Record online : 7 DEC 2012, DOI: 10.1111/ijlh.12036

  14. You have free access to this content
    Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    British Journal of Haematology

    Volume 121, Issue 5, June 2003, Pages: 749–757, The International Myeloma Working Group

    Version of Record online : 28 MAY 2003, DOI: 10.1046/j.1365-2141.2003.04355.x

  15. Current concepts on monoclonal gammopathies

    Australian and New Zealand Journal of Medicine

    Volume 22, Issue 3, June 1992, Pages: 291–302, R. A. Kyle

    Version of Record online : 25 MAR 2008, DOI: 10.1111/j.1445-5994.1992.tb02127.x

  16. You have free access to this content
    An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma

    American Journal of Hematology

    Volume 84, Issue 10, October 2009, Pages: 650–656, Ravi Vij, Noemi Horvath, Andrew Spencer, Kerry Taylor, Saroj Vadhan-Raj, Robert Vescio, Judy Smith, Yi Qian, Howard Yeh and Susie Jun

    Version of Record online : 25 JUL 2009, DOI: 10.1002/ajh.21509

  17. You have full text access to this Open Access content
    Serum M-spike and transplant outcome in patients with multiple myeloma

    Cancer Science

    Volume 98, Issue 7, July 2007, Pages: 1035–1040, David Dingli, Jorge M. Pacheco, Angela Dispenzieri, Suzanne R. Hayman, Shaji K. Kumar, Martha Q. Lacy, Dennis A. Gastineau and Morie A. Gertz

    Version of Record online : 4 MAY 2007, DOI: 10.1111/j.1349-7006.2007.00499.x

  18. You have free access to this content
    V. Smoldering multiple myeloma

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 33–37, María-Victoria Mateos and Jesús San Miguel

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2213

  19. You have free access to this content
    Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

    American Journal of Hematology

    Volume 86, Issue 3, March 2011, Pages: 251–255, Shaji K. Kumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, Tow Tan, Shirshendu Sinha, Nelson Leung, Robert A. Kyle, S. Vincent Rajkumar and Morie A. Gertz

    Version of Record online : 15 FEB 2011, DOI: 10.1002/ajh.21948

  20. Multiple Myeloma

    Postgraduate Haematology, Sixth edition

    Jesús San-Miguel, Joan Bladé, Pages: 577–598, 2010

    Published Online : 16 NOV 2010, DOI: 10.1002/9781444323160.ch31